z-logo
open-access-imgOpen Access
Adverse events, healthcare interventions and healthcare utilization during home infusion therapy with daptomycin and vancomycin: a propensity score-matched cohort study
Author(s) -
Nabin K. Shrestha,
P Mason,
Steven Gordon,
Elizabeth Neuner,
Benjamin Nutter,
Colin O’Rourke,
Susan J. Rehm
Publication year - 2014
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkt512
Subject(s) - daptomycin , medicine , adverse effect , psychological intervention , antimicrobial , health care , intensive care medicine , vancomycin , cohort , propensity score matching , antimicrobial stewardship , emergency medicine , antibiotics , staphylococcus aureus , antibiotic resistance , nursing , microbiology and biotechnology , bacteria , biology , economic growth , economics , genetics
Vancomycin and daptomycin are the two most frequently prescribed parenteral antimicrobials for resistant Gram-positive bacterial infections. The purpose of this study was to compare antimicrobial adverse event rates and associated healthcare interventions and healthcare utilization in patients treated with the two antimicrobials.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom